• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Gonadotropin-releasing Hormone Agonist Drugs Market Research Report 2020

report cover
  • 29 October 2020
  • Healthcare
  • 90 Pages
  • Report Code: 24LS-21797
  • Formate :   
Download FREE Report Sample Download PDF File

Gonadotropin releasing Hormone Agonist Drugs -MARKET ADVISORY SERVICES

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Gonadotropin-releasing Hormone Agonist Drugs market is segmented into
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other

Segment by Application
Hospital
Pharmacy
Other

Global Gonadotropin-releasing Hormone Agonist Drugs Market: Regional Analysis
The Gonadotropin-releasing Hormone Agonist Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Gonadotropin-releasing Hormone Agonist Drugs market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Global Gonadotropin-releasing Hormone Agonist Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Gonadotropin-releasing Hormone Agonist Drugs market include:
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen
Sanofi
Endo
1 Gonadotropin-releasing Hormone Agonist Drugs Market Overview
1.1 Product Overview and Scope of Gonadotropin-releasing Hormone Agonist Drugs
1.2 Gonadotropin-releasing Hormone Agonist Drugs Segment by Type
1.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Leuprorelin
1.2.3 Goserelin
1.2.4 Taltirelin
1.2.5 Histrelin
1.2.6 Other
1.3 Gonadotropin-releasing Hormone Agonist Drugs Segment by Application
1.3.1 Gonadotropin-releasing Hormone Agonist Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size Estimates and Forecasts
1.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue 2015-2026
1.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Sales 2015-2026
1.4.3 Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region: 2020 Versus 2026
1.5 Gonadotropin-releasing Hormone Agonist Drugs Industry
1.6 Gonadotropin-releasing Hormone Agonist Drugs Market Trends

2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Competition by Manufacturers
2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Sites, Area Served, Product Type
2.5 Gonadotropin-releasing Hormone Agonist Drugs Market Competitive Situation and Trends
2.5.1 Gonadotropin-releasing Hormone Agonist Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Gonadotropin-releasing Hormone Agonist Drugs Players (Opinion Leaders)

3 Gonadotropin-releasing Hormone Agonist Drugs Retrospective Market Scenario by Region
3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.3.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.3.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.4.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.4.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region
3.5.2 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.6.1 Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.6.2 Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.7.2 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Gonadotropin-releasing Hormone Agonist Drugs Historic Market Analysis by Type
4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2015-2020)
4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price Market Share by Type (2015-2020)
4.4 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Gonadotropin-releasing Hormone Agonist Drugs Historic Market Analysis by Application
5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)
5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Gonadotropin-releasing Hormone Agonist Drugs Business
6.1 AbbVie
6.1.1 Corporation Information
6.1.2 AbbVie Description, Business Overview and Total Revenue
6.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AbbVie Products Offered
6.1.5 AbbVie Recent Development
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description, Business Overview and Total Revenue
6.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 AstraZeneca Products Offered
6.2.5 AstraZeneca Recent Development
6.3 Ferring
6.3.1 Ferring Corporation Information
6.3.2 Ferring Description, Business Overview and Total Revenue
6.3.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Ferring Products Offered
6.3.5 Ferring Recent Development
6.4 TerSera Therapeutics
6.4.1 TerSera Therapeutics Corporation Information
6.4.2 TerSera Therapeutics Description, Business Overview and Total Revenue
6.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 TerSera Therapeutics Products Offered
6.4.5 TerSera Therapeutics Recent Development
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description, Business Overview and Total Revenue
6.5.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Takeda Products Offered
6.5.5 Takeda Recent Development
6.6 LIVZON
6.6.1 LIVZON Corporation Information
6.6.2 LIVZON Description, Business Overview and Total Revenue
6.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 LIVZON Products Offered
6.6.5 LIVZON Recent Development
6.7 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description, Business Overview and Total Revenue
6.6.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ipsen Products Offered
6.7.5 Ipsen Recent Development
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description, Business Overview and Total Revenue
6.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sanofi Products Offered
6.8.5 Sanofi Recent Development
6.9 Endo
6.9.1 Endo Corporation Information
6.9.2 Endo Description, Business Overview and Total Revenue
6.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Endo Products Offered
6.9.5 Endo Recent Development

7 Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Cost Analysis
7.1 Gonadotropin-releasing Hormone Agonist Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gonadotropin-releasing Hormone Agonist Drugs
7.4 Gonadotropin-releasing Hormone Agonist Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gonadotropin-releasing Hormone Agonist Drugs Distributors List
8.3 Gonadotropin-releasing Hormone Agonist Drugs Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Agonist Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Agonist Drugs by Type (2021-2026)
10.2 Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Agonist Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Agonist Drugs by Application (2021-2026)
10.3 Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gonadotropin-releasing Hormone Agonist Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Gonadotropin-releasing Hormone Agonist Drugs by Region (2021-2026)
10.4 North America Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2021-2026)
10.5 Europe Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2021-2026)
10.7 Latin America Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables

Table 1. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Comparison by Application: 2020 VS 2026

Table 3. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)

Table 4. Global Key Gonadotropin-releasing Hormone Agonist Drugs Manufacturers Covered in This Study

Table 5. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Manufacturers (2015-2020)

Table 6. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Manufacturers (2015-2020)

Table 7. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Manufacturers (2015-2020)

Table 9. Global Market Gonadotropin-releasing Hormone Agonist Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020)

Table 10. Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Sales Sites and Area Served

Table 11. Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Product Types

Table 12. Global Gonadotropin-releasing Hormone Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Gonadotropin-releasing Hormone Agonist Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonadotropin-releasing Hormone Agonist Drugs as of 2019)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Main Points Interviewed from Key Gonadotropin-releasing Hormone Agonist Drugs Players

Table 16. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Region (2015-2020)

Table 17. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2015-2020)

Table 18. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) by Region (2015-2020)

Table 19. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2015-2020)

Table 20. North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2015-2020) (K Units)

Table 21. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2015-2020)

Table 22. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2015-2020) (US$ Million)

Table 23. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2015-2020)

Table 24. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2015-2020) (K Units)

Table 25. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2015-2020)

Table 26. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2015-2020) (US$ Million)

Table 27. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2015-2020)

Table 28. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Region (2015-2020) (K Units)

Table 29. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2015-2020)

Table 30. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Region (2015-2020) (US$ Million)

Table 31. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2015-2020)

Table 32. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2015-2020) (K Units)

Table 33. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2015-2020)

Table 34. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2015-2020) (US$ Million)

Table 35. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2015-2020)

Table 36. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Country (2015-2020) (K Units)

Table 37. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country (2015-2020)

Table 38. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Country (2015-2020) (US$ Million)

Table 39. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country (2015-2020)

Table 40. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Type (2015-2020)

Table 41. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2015-2020)

Table 42. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) by Type (2015-2020)

Table 43. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Type (2015-2020)

Table 44. Global Gonadotropin-releasing Hormone Agonist Drugs Price (USD/Unit) by Type (2015-2020)

Table 45. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) by Application (2015-2020)

Table 46. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)

Table 47. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate by Application (2015-2020)

Table 48. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 49. AbbVie Description and Business Overview

Table 50. AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 51. AbbVie Main Product

Table 52. AbbVie Recent Development

Table 53. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 54. AstraZeneca Corporation Information

Table 55. AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 56. AstraZeneca Main Product

Table 57. AstraZeneca Recent Development

Table 58. Ferring Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 59. Ferring Corporation Information

Table 60. Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 61. Ferring Main Product

Table 62. Ferring Recent Development

Table 63. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 64. TerSera Therapeutics Corporation Information

Table 65. TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 66. TerSera Therapeutics Main Product

Table 67. TerSera Therapeutics Recent Development

Table 68. Takeda Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 69. Takeda Corporation Information

Table 70. Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 71. Takeda Main Product

Table 72. Takeda Recent Development

Table 73. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 74. LIVZON Corporation Information

Table 75. LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 76. LIVZON Main Product

Table 77. LIVZON Recent Development

Table 78. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 79. Ipsen Corporation Information

Table 80. Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 81. Ipsen Main Product

Table 82. Ipsen Recent Development

Table 83. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 84. Sanofi Corporation Information

Table 85. Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 86. Sanofi Main Product

Table 87. Sanofi Recent Development

Table 88. Endo Gonadotropin-releasing Hormone Agonist Drugs Corporation Information

Table 89. Endo Corporation Information

Table 90. Endo Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

Table 91. Endo Main Product

Table 92. Endo Recent Development

Table 93. Sales Base and Market Concentration Rate of Raw Material

Table 94. Key Suppliers of Raw Materials

Table 95. Gonadotropin-releasing Hormone Agonist Drugs Distributors List

Table 96. Gonadotropin-releasing Hormone Agonist Drugs Customers List

Table 97. Market Key Trends

Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 99. Key Challenges

Table 100. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Forecast by Type (2021-2026)

Table 101. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share Forecast by Type (2021-2026)

Table 102. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Forecast by Type (2021-2026)

Table 103. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)

Table 104. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Forecast by Application (2021-2026)

Table 105. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Forecast by Application (2021-2026)

Table 106. Global Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) Forecast by Region (2021-2026)

Table 107. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share Forecast by Region (2021-2026)

Table 108. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Region (2021-2026) (US$ Million)

Table 109. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share Forecast by Region (2021-2026)

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Gonadotropin-releasing Hormone Agonist Drugs

Figure 2. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type: 2020 VS 2026

Figure 3. Leuprorelin Product Picture

Figure 4. Goserelin Product Picture

Figure 5. Taltirelin Product Picture

Figure 6. Histrelin Product Picture

Figure 7. Other Product Picture

Figure 8. Global Gonadotropin-releasing Hormone Agonist Drugs Consumption Market Share by Application: 2020 VS 2026

Figure 9. Hospital

Figure 10. Pharmacy

Figure 11. Other

Figure 12. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size 2015-2026 (US$ Million)

Figure 13. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Capacity (K Units) (2015-2026)

Figure 14. Global Gonadotropin-releasing Hormone Agonist Drugs Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Manufacturers in 2020

Figure 16. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Manufacturers in 2019

Figure 17. The Global 5 and 10 Largest Players: Market Share by Gonadotropin-releasing Hormone Agonist Drugs Revenue in 2019

Figure 18. Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 19. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2015-2020)

Figure 20. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region in 2019

Figure 21. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2015-2020)

Figure 22. Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region in 2019

Figure 23. North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country in 2019

Figure 24. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country in 2019

Figure 25. U.S. Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 26. U.S. Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 27. Canada Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 28. Canada Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 29. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country in 2019

Figure 30. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country in 2019

Figure 31. Germany Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 32. Germany Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 33. France Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 34. France Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 35. U.K. Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 36. U.K. Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 37. Italy Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 38. Italy Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 39. Russia Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 40. Russia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 41. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region in 2019

Figure 42. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region in 2019

Figure 43. China Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 44. China Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 46. Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. South Korea Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 48. South Korea Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 49. India Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 50. India Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. Australia Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 52. Australia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. Taiwan Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 54. Taiwan Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Indonesia Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 56. Indonesia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Thailand Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 58. Thailand Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Malaysia Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 60. Malaysia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Philippines Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 62. Philippines Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 63. Vietnam Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 64. Vietnam Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country in 2019

Figure 66. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country in 2019

Figure 67. Mexico Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 68. Mexico Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. Brazil Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 70. Brazil Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. Argentina Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 72. Argentina Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Country in 2019

Figure 74. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Country in 2019

Figure 75. Turkey Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 76. Turkey Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 78. Saudi Arabia Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. U.A.E Gonadotropin-releasing Hormone Agonist Drugs Sales Growth Rate (2015-2020) (K Units)

Figure 80. U.A.E Gonadotropin-releasing Hormone Agonist Drugs Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Sales Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type (2015-2020)

Figure 82. Sales Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type in 2019

Figure 83. Revenue Share of Gonadotropin-releasing Hormone Agonist Drugs by Type (2015-2020)

Figure 84. Revenue Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type in 2019

Figure 85. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Growth by Type (2015-2020) (K Units)

Figure 86. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2015-2020)

Figure 87. Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2019

Figure 88. Global Revenue Share of Gonadotropin-releasing Hormone Agonist Drugs by Application (2015-2020)

Figure 89. Global Revenue Share of Gonadotropin-releasing Hormone Agonist Drugs by Application in 2020

Figure 90. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018

Figure 91. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 92. Ferring Total Revenue (US$ Million): 2019 Compared with 2018

Figure 93. TerSera Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 94. Takeda Total Revenue (US$ Million): 2019 Compared with 2018

Figure 95. LIVZON Total Revenue (US$ Million): 2019 Compared with 2018

Figure 96. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 97. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 98. Endo Total Revenue (US$ Million): 2019 Compared with 2018

Figure 99. Price Trend of Key Raw Materials

Figure 100. Manufacturing Cost Structure of Gonadotropin-releasing Hormone Agonist Drugs

Figure 101. Manufacturing Process Analysis of Gonadotropin-releasing Hormone Agonist Drugs

Figure 102. Gonadotropin-releasing Hormone Agonist Drugs Industrial Chain Analysis

Figure 103. Channels of Distribution

Figure 104. Distributors Profiles

Figure 105. Porter's Five Forces Analysis

Figure 106. North America Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 107. North America Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 108. Europe Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 109. Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 110. Latin America Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 111. Latin America Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 112. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 113. Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 114. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)

Figure 115. Asia Pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 116. Bottom-up and Top-down Approaches for This Report

Figure 117. Data Triangulation

Figure 118. Key Executives Interviewed

AbbVie

AstraZeneca

Ferring

TerSera Therapeutics

Takeda

LIVZON

Ipsen

Sanofi

Endo

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2465

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase